132 related articles for article (PubMed ID: 36720321)
1. Discovery of orally bioavailable inhibitors of MALT1 with in vivo activity for psoriasis.
Nunettsu Asaba K; Okimura K; Adachi Y; Tokumaru K; Goto Y; Fujii S; Watanabe A; Sakai C; Sakurada E; Amikura K; Aoki T
Bioorg Med Chem Lett; 2023 Feb; 82():129155. PubMed ID: 36720321
[TBL] [Abstract][Full Text] [Related]
2. Mucosa-associated lymphoid tissue lymphoma translocation protein 1 in rheumatoid arthritis: Longitudinal change after treatment and correlation with treatment efficacy of tumor necrosis factor inhibitors.
Wang F; Liu G; Xiang L; Yuan J; Tao Y; Zhang L; Zhang A; Chang X
J Clin Lab Anal; 2022 Jun; 36(6):e24449. PubMed ID: 35500150
[TBL] [Abstract][Full Text] [Related]
3. MALT1 targeting suppresses CARD14-induced psoriatic dermatitis in mice.
Van Nuffel E; Staal J; Baudelet G; Haegman M; Driege Y; Hochepied T; Afonina IS; Beyaert R
EMBO Rep; 2020 Jul; 21(7):e49237. PubMed ID: 32343482
[TBL] [Abstract][Full Text] [Related]
4. Discovery and optimization of cyclohexane-1,4-diamines as allosteric MALT1 inhibitors.
Schiesser S; Hajek P; Pople HE; Käck H; Öster L; Cox RJ
Eur J Med Chem; 2022 Jan; 227():113925. PubMed ID: 34742013
[TBL] [Abstract][Full Text] [Related]
5. Management of gastric mucosa-associated lymphoid tissue lymphoma in patients with extra copies of the
Iwamuro M; Takenaka R; Nakagawa M; Moritou Y; Saito S; Hori S; Inaba T; Kawai Y; Toyokawa T; Tanaka T; Yoshino T; Okada H
World J Gastroenterol; 2017 Sep; 23(33):6155-6163. PubMed ID: 28970731
[TBL] [Abstract][Full Text] [Related]
6. Keratinocyte-intrinsic BCL10/MALT1 activity initiates and amplifies psoriasiform skin inflammation.
Kurgyis Z; Vornholz L; Pechloff K; Kemény LV; Wartewig T; Muschaweckh A; Joshi A; Kranen K; Hartjes L; Möckel S; Steiger K; Hameister E; Volz T; Mellett M; French LE; Biedermann T; Korn T; Ruland J
Sci Immunol; 2021 Nov; 6(65):eabi4425. PubMed ID: 34826258
[TBL] [Abstract][Full Text] [Related]
7. Refining the dermatological spectrum in primary immunodeficiency: mucosa-associated lymphoid tissue lymphoma translocation protein 1 deficiency mimicking Netherton/Omenn syndromes.
Wiegmann H; Reunert J; Metze D; Marquardt T; Engel T; Kunde V; Ehl S; Foell D; van den Heuvel I; Oji V; Wittkowski H
Br J Dermatol; 2020 Jan; 182(1):202-207. PubMed ID: 31049936
[TBL] [Abstract][Full Text] [Related]
8. Blood MALT1 expression could help predict treatment outcomes in psoriasis patients, especially in those receiving biologics.
Liu Q; Zhang Y; Xu B; Jin X; Yang T; Fan L
Immun Inflamm Dis; 2024 Apr; 12(4):e1235. PubMed ID: 38578002
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic analysis of gastric mucosa-associated lymphoid tissue lymphoma with or without c-Met expression.
Omote R; Gion Y; Omote S; Tari A; Tanaka T; Nishikori A; Yoshino T; Sato Y
Med Mol Morphol; 2020 Sep; 53(3):149-155. PubMed ID: 31897734
[TBL] [Abstract][Full Text] [Related]
10. MALT1 sequencing analyses in marginal zone B-cell lymphomas reveal mutations in the translocated MALT1 allele in an IGH-MALT1-positive MALT lymphoma.
Akyüz N; Albert-Konetzny N; Pott C; Callet-Bauchu E; Bokemeyer C; Murga Penas EM; Dierlamm J
Leuk Lymphoma; 2017 Oct; 58(10):2480-2484. PubMed ID: 28278699
[No Abstract] [Full Text] [Related]
11. Structure-activity relationship studies of 3-substituted pyrazoles as novel allosteric inhibitors of MALT1 protease.
Asaba KN; Adachi Y; Tokumaru K; Watanabe A; Goto Y; Aoki T
Bioorg Med Chem Lett; 2021 Jun; 41():127996. PubMed ID: 33775836
[TBL] [Abstract][Full Text] [Related]
12. MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma.
Sanchez-Izquierdo D; Buchonnet G; Siebert R; Gascoyne RD; Climent J; Karran L; Marin M; Blesa D; Horsman D; Rosenwald A; Staudt LM; Albertson DG; Du MQ; Ye H; Marynen P; Garcia-Conde J; Pinkel D; Dyer MJ; Martinez-Climent JA
Blood; 2003 Jun; 101(11):4539-46. PubMed ID: 12560219
[TBL] [Abstract][Full Text] [Related]
13. Identification of Novel Fused Heteroaromatics-Based MALT1 Inhibitors by High-Throughput Screening to Treat B Cell Lymphoma.
Liang X; Sun C; Li C; Yu H; Wei X; Liu X; Bao W; Shi Y; Sun X; Khamrakulov M; Yang C; Liu H
J Med Chem; 2021 Jul; 64(13):9217-9237. PubMed ID: 34181850
[TBL] [Abstract][Full Text] [Related]
14. MALT1 protease: a new therapeutic target in B lymphoma and beyond?
McAllister-Lucas LM; Baens M; Lucas PC
Clin Cancer Res; 2011 Nov; 17(21):6623-31. PubMed ID: 21868762
[TBL] [Abstract][Full Text] [Related]
15. T(14;18)(q32;q21) involving MALT1 and IGH genes in an extranodal diffuse large B-cell lymphoma.
Cook JR; Sherer M; Craig FE; Shekhter-Levin S; Swerdlow SH
Hum Pathol; 2003 Nov; 34(11):1212-5. PubMed ID: 14652825
[TBL] [Abstract][Full Text] [Related]
16. Targeted deep sequencing of gastric marginal zone lymphoma identified alterations of TRAF3 and TNFAIP3 that were mutually exclusive for MALT1 rearrangement.
Hyeon J; Lee B; Shin SH; Yoo HY; Kim SJ; Kim WS; Park WY; Ko YH
Mod Pathol; 2018 Sep; 31(9):1418-1428. PubMed ID: 29765142
[TBL] [Abstract][Full Text] [Related]
17. The t(14;18)(q32;q21)/IGH-MALT1 translocation in MALT lymphomas contains templated nucleotide insertions and a major breakpoint region similar to follicular and mantle cell lymphoma.
Murga Penas EM; Callet-Bauchu E; Ye H; Gazzo S; Berger F; Schilling G; Albert-Konetzny N; Vettorazzi E; Salles G; Wlodarska I; Du MQ; Bokemeyer C; Dierlamm J
Blood; 2010 Mar; 115(11):2214-9. PubMed ID: 19965626
[TBL] [Abstract][Full Text] [Related]
18. MALT1 positively relates to Th17 cells, inflammation/activity degree, and its decrement along with treatment reflects TNF inhibitor response in ankylosing spondylitis patients.
Yuan J; Xiang L; Wang F; Zhang L; Liu G; Chang X; Zhang A; Tao Y
J Clin Lab Anal; 2022 Jul; 36(7):e24472. PubMed ID: 35622982
[TBL] [Abstract][Full Text] [Related]
19. Psoriasis mutations disrupt CARD14 autoinhibition promoting BCL10-MALT1-dependent NF-κB activation.
Howes A; O'Sullivan PA; Breyer F; Ghose A; Cao L; Krappmann D; Bowcock AM; Ley SC
Biochem J; 2016 Jun; 473(12):1759-68. PubMed ID: 27071417
[TBL] [Abstract][Full Text] [Related]
20. Differential requirement for Malt1 in T and B cell antigen receptor signaling.
Ruland J; Duncan GS; Wakeham A; Mak TW
Immunity; 2003 Nov; 19(5):749-58. PubMed ID: 14614861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]